Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin

Recurrence of Clostridium difficile infection (CDI) occurs in approximately 25% of successfully treated patients. Two phase 3 randomized, double-blind trials were conducted at 154 sites in the United States, Canada, and Europe to compare fidaxomicin vs vancomycin in treating CDI. Patients with CDI r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornely, Oliver A., Miller, Mark A., Louie, Thomas J., Crook, Derrick W., Gorbach, Sherwood L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388030/
https://www.ncbi.nlm.nih.gov/pubmed/22752865
http://dx.doi.org/10.1093/cid/cis462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388030/
https://www.ncbi.nlm.nih.gov/pubmed/22752865
http://dx.doi.org/10.1093/cid/cis462

Ejemplares similares